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Accepted 15 November 2012AbstractObjective: This study investigated the occurrence of peritoneal fluid in women undergoing intrauterine insemination (IUI) and its correlation
with the stage of pelvic endometriosis and its influence on pregnancy outcomes.
Materials and Methods: A retrospective caseecontrol design was used to recruit 272 infertile women with pelvic endometriosis. The treatment
protocol consisted of controlled ovarian hyperstimulation with downregulation and gonadotropin for IUI treatment following ultrasound and
laparoscopic intervention. The amount and color of the peritoneal fluid were determined during laparoscopy.
Results: The mean amount of peritoneal fluid with pelvic endometriosis that was detected using transvaginal ultrasound wasw15.1 mL. Women
whose cycles contained more peritoneal fluid had significantly lower pregnancy rates (17.2% and 31.3%, respectively). The total clinical
pregnancy rate was not significantly different between the two groups with reddish and yellowish peritoneal fluid who had pelvic endometriosis.
Conclusion: Pelvic endometriosis and peritoneal fluid, detected through vaginal ultrasound, have negative effects on the pregnancy outcome of
IUI treatment.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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The effect of peritoneal fluid with endometriosis on preg-
nancy outcomes has been studied extensively in recent years.
Most studies have reported that the peritoneal fluid of endo-
metriosis exhibits embryo toxicity, and pregnancy rates are low
in women with severe endometriosis [1e3]. This may be
because fluid accumulates in the cul-de-sac, disturbing oocyte
pickup and tubal sperm motility [4e6]. In addition, nitric oxide
from peritoneal fluid, generated by endometriosis, can reduce
the pregnancy rates in these patients [7]. An additional study,
using peritoneal fluid recovered from a mouse with endome-
triosis, demonstrated its adverse effects on early embryonic* Corresponding author. Department of Obstetrics and Gynecology, Shuang
Ho Hospital and Taipei Medical University, Number 291, Zhongzheng Road,
Zhonghe District, Taipei 23561, Taiwan.
E-mail address: 12025@s.tmu.edu.tw (P.-H. Chen).
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http://dx.doi.org/10.1016/j.tjog.2013.10.010development [8]. However, fluid accumulation within the cul-
de-sac, which is detected using a transvaginal ultrasound prior
to laparoscopy, has been sporadically reported in previous
studies, and most of these cases were reported to entail pelvic
endometriosis [9e11]. The frequency of occurrence for this
complication in women with unexplained infertility and
whether women with other indications of intrauterine insemi-
nation (IUI) have this problem remain unknown. This study
reports on the original observation of peritoneal fluid in
consecutive series of laparoscopic results related to the lower
pregnancy rate of infertile patients undergoing IUI treatment.
Materials and methodsPatient selection and study designThis study was approved by the Institutional Review Board
of Taipei Medical University Hospital. A total of 272 infertilecs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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triosis and/or endometrioma were enrolled and retrospectively
reviewed using our IUI database system from January 2005 to
December 2011. The inclusion criteria comprised several
factors: (1) prelaparoscopic transvaginal ultrasound revealed
pelvic endometriosis and/or endometrioma; (2) laparoscopic
intervention disclosed pelvic endometriosis with peritoneal
fluid in the cul-de-sac; (3) chromopertubation indicated the
patency of the bilateral tubes; and (4) a histologically
confirmed diagnosis of endometriosis and/or endometrioma.
Patients who had received exploratory laparotomy for endo-
metriosis and/or endometrioma were excluded. Surgical
treatment consisted of a thorough laparoscopic electro-
cauterization/ablation or the excision of the peritoneal and
nonperitoneal endometriotic lesion, lysis of adhesion, and the
appropriate enucleation of the endometrioma. The volume and
color of the peritoneal fluid were recorded. Patients who had
peritoneal fluid were classified into two groups. Group 1
consisted of 49 patients with peritoneal fluid that was detected
using transvaginal ultrasound, and Group 2 consisted of 223
patients without peritoneal fluid, as determined by trans-
vaginal ultrasound. Transvaginal ultrasound using an Ultra-
mark 9 HDI (Advanced Technology Laboratories, Bothell,
WA, USA) with a 5e9-MHz multi-frequency transvaginal
probe was performed to detect the pelvic pathology and
peritoneal fluid. Fluid accumulation within the cul-de-sac was
defined as an echolucent ring configuration that was distended
by a certain amount of fluid between the posterior uterine wall
and the intestinal loop linings in a sagittal view.ART protocolsTable 1Following laparoscopic operation, patients received the
gonadotropin-releasing hormone agonist leuprorelin (Leuplin
Depot, 3.75 mg; Takeda Chemical Industries, Osaka, Japan) at
1.88 mg/month for 2 consecutive months. Four weeks
following the administration of the second dose of leuprorelin,
each patient received exogenous intramuscular gonadotropin
of recombinant FSH (Serono, Geneva, Switzerland). When the
leading follicle reached 18 mm in diameter, 250 mg recom-
binant human chorionic gonadotropin (hCG) was administered
subcutaneously. IUI was performed w36 hours later. The
luteal phase was supported with micronized progesterone,
600 mg/day transvaginally for 2 weeks, and an additional 1500
IU hCG was administered on Day 6 following IUI.
Pregnancy was achieved by increasing the serum b-hCG
levels to >5 mIU/mL on Day 16 following IUI, and trans-
vaginal ultrasound was used to reveal heart activity until Week
6 of gestation.Analysis of the stages of pelvic endometriosis and correlation with the color of
peritoneal fluid determined by laparoscopy.Parameters of comparisonReddish color (n ¼ 242) Yellowish color (n ¼ 30) p
Stage I 164 (89.62%) 19 (10.38%) 0.003
Stage II 38 (90.48%) 4 (9.52%) 0.006
Stage III 24 (88.89 %) 3 (11.11%) 0.004
Stage IV 16 (80.0%) 4 (20.0%) 0.002
Data are presented as n (%).The parameters of comparison included maternal age,
paternal age, peak serum estradiol, progesterone level, and
sperm motility. The pregnancy rates were compared between
the two groups. The stage of pelvic endometriosis and the
amount and color of the peritoneal fluid were assessed.Statistical analysisContinuous data were summarized as means  standard
deviation. The ManneWhitney rank-sum test was used for
mean comparisons, and Fisher’s exact test was used to
compare the proportions. The significance of the groups was
evaluated using the Student t test. Statistical analyses were
performed using SPSS version 18.0 (SPSS Inc., Chicago, IL,
USA). All p values were two-sided, and p < 0.05 was
considered statistically significant.
Results
Table 1 shows the color of the peritoneal fluid in relation to
the stage of pelvic endometriosis. Reddish peritoneal fluid
accounted for 88.9% of the fluid, whereas yellowish fluid
accounted for 11.03%. Reddish and yellowish peritoneal fluid
accounted for 89.6% and 10.3% in Stage I, 90.4% and 9.5% in
Stage II, 88.8% and 11.1% in Stage III, and 80% and 20% in
Stage IV, respectively. No differences in the color of the
peritoneal fluid were observed in correlation with the stage of
pelvic endometriosis ( p ¼ 0.612).
Table 2 shows a comparison of the clinical characteristics
of the two groups after IUI treatment. Preoperative peritoneal
fluid accumulation detected by transvaginal ultrasound had an
incidence of 18.0% (49/272). Substantially more peritoneal
fluid was detected using vaginal ultrasounds (15.14  0.63 vs.
8.54  0.39 mL, p < 0.001), and pregnancy rates were lower
among women with cycles in which peritoneal fluid was
detected through vaginal ultrasound (16.3% vs. 31.3%,
p ¼ 0.035). There were no significant differences among pa-
tient age, duration of infertility, gonadotropin dose, motility,
amount of washed sperm, estradiol on hCG day, progesterone
on hCG day, endometrial thickness on the day of IUI, mean
number of follicles, or multiple pregnancies. No ovarian hy-
perstimulation syndrome occurred in this study.
Table 3 shows the correlation of peritoneal fluid color with
pregnancy outcome. The pregnancy rate with reddish fluid was
30.4% in Stage I, and 36.8% with yellowish fluid. The preg-
nancy rate with reddish fluid was 23.6% in Stage II, and 25%
with yellowish fluid. The pregnancy rate with reddish fluid
was 16.6% in Stage III, and 33.3% with yellowish fluid. The
pregnancy rate with reddish fluid was 37.5% in Stage IV, and
0% with yellowish fluid. For the yellowish fluid, pregnancy
rates were higher in Stages IeIII than in Stage IV, although the
P value was not significant ( p ¼ 0.491). The total clinical
pregnancy rate was not significantly different between the
Table 2
Comparison of intrauterine insemination cycles with peritoneal fluid detected
by transvaginal ultrasound and those not detected before laparoscopy.
Cycles with
fluid (n ¼ 49)
Cycles without
fluid (n ¼ 223)
p
Age (y) 33.37  0.54 33.81  0.23 0.912
Duration of infertility (y) 3.22  0.27 3.37  0.16 0.083
Gonadotrophins dose (IU) 1350  75 1275  75 0.701
E2 (pg/mL) on hCG day 831.00  80.4 800.8  42.2 0.104
Mean follicles (n) 3.2  0.4 3.4  0.4 0.112
P (ng/mL) on hCG day 0.74  0.09 1.17  0.38 0.376
No. of washed sperm (106/mL) 42.43  3.88 43.96  1.96 0.702
Motility of washed sperm (%) 93.6  0.35 93.8  0.28 0.693
Endometrial thickness (mm) 11.8  0.42 11.6  0.41 0.382
Peritoneal fluid volume (mL) 15.14  0.63 8.54  0.39 <0.001
No. of pregnancies, n (%) 8 (16.32 %) 70 (31.39%) 0.035
No. of multiple pregnancies,
n (%)
1 (12.5%) 6 (8.5%) 0.215
No. of ectopic pregnancies,
n (%)
1 (2.0 %) 2 (0.8 %) 0.312
No. of abortions, n (%) 1 (12.5%) 6 (8.5 %) 0.221
Data are presented as n (%) or mean  standard deviation.
E2 ¼ estradiol; hCG ¼ human chorionic gonadotropin; P ¼ progesterone.
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30.0%, p ¼ 0.865).
Discussion
The reasons for subfertility in patients with pelvic endo-
metriosis remain unclear. Previous studies have suggested that
25e50% of infertile women have pelvic endometriosis, and
that 30e50% of women with endometriosis are infertile
[12,13]. Several mechanisms have been proposed to elucidate
the association of endometriosis and infertility [2,13]. In the
past decade, several studies have demonstrated that women
with endometriosis have an increased volume of peritoneal
fluid, increased concentration of activated macrophages, and
increased peritoneal fluid concentrations of prostaglandins,
interleukin-1, tumor necrosis fluid factor, and proteases.
Peritoneal fluid from women with endometriosis reportedly
contains an ovum capture inhibitor that prevents normal
cumulusefimbrial interactions [14]. These alterations may
adversely affect the functions of the oocytes, sperm, embryos,
or the fallopian tubes, causing subsequent implantation dis-
turbances. Terrance et al [9] proposed that the volume of
peritoneal fluid is positively correlated with the severity of
endometriosis. However, the volume of peritoneal fluid was
not significantly positively correlated with the stage of pelvic
endometriosis in our data.Table 3
Analysis of the pregnancy rates of intrauterine insemination cycles correlated
with the stage of pelvic endometriosis and the color of peritoneal fluid.
Reddish color (n ¼ 242) Yellowish color (n ¼ 30) p
Stage I 50/164 (30.5%) 7/19 (36.8%) 0.157
Stage II 9/38 (23.6 %) 1/4 (25.0%) 0.125
Stage III 4/24 (16.6 %) 1/3 (33.3%) 0.121
Stage IV 6/16 (37.5 %) 0/4 (0.0%) 0.223
Data are presented as n (%).The endometriosis patients who achieved pregnancy had a
significantly lower mean of fluid volume than those who did
not become pregnant during a 2-year follow-up period in the
study of Syrop et al [1]. In their study, patients with a peri-
toneal fluid volume <12 mL achieved pregnancy in nearly half
the time as those with a volume >12 mL. In our study, patients
with a mean peritoneal fluid volume of 15.1 mL, detected
using transvaginal ultrasound, had lower pregnancy rates after
IUI treatment. All of our cases of pelvic endometriosis with
peritoneal fluid within the cul-de-sac were disclosed by lapa-
roscopic intervention, but only when the amount of peritoneal
fluid wasw15 mL could it be detected using the sagittal view
of transvaginal ultrasound. This indicates that small amounts
of peritoneal fluid within the cul-de-sac cannot be detected
using transvaginal ultrasound. However, our data showed that
greater volumes of peritoneal fluid may have more negative
effects on pregnancy outcomes.
Recent studies have suggested that menstrual effluent con-
tains factors that induce the local destruction of the peritoneal
mesothelium, thereby creating adhesion sites for endometrial
cells. Van et al [15] found higher levels of hemoglobin in the
peritoneal fluid of patients with endometriosis. This hypothesis
is based on the possibility that hemoglobin, when released into
the peritoneal cavity following red blood cell lysis, may activate
these processes. All products of hemoglobin catabolism are
biologically active, including heme, which is cleaved by heme
oxygenase into iron, carbon monoxide, and biliverdin, which is
further converted into bilirubin. Various colors of peritoneal
fluid in endometriosis patients may represent different statuses.
Heme may cause a reddish color, and bilirubin may cause a
yellowish color. However, no differences in color distribution
were observed among the stages of pelvic endometriosis ac-
cording to our statistical results. Therefore, we could not
determine the metabolic pathway of endometriosis because of
the complex interactions between pelvic endometriosis and
peritoneal fluid.
The color of peritoneal fluid had a significant relationship
with pregnancy outcomes. The pregnancy rates with yellowish
fluid in Stages IeIII were better than those with reddish fluid
in the same stages. However, no pregnancies occurred with
yellowish fluid in Stage IV. This shows that changes in the
peritoneal cavity may be more crucial for implantation than
peritoneal fluid. As a result of the small number of severe
endometriosis cases in this study, we did not emphasize the
effect of peritoneal fluid on the severity of endometriosis.
Peritoneal fluid has not been placed in the revised classi-
fication of endometriosis by the American Society of Repro-
ductive Medicine [16] since 1996. Most previous studies have
revealed that peritoneal fluid has a detrimental effect on in vivo
and in vitro model assays [6,10,17e20]. This study recom-
mends that peritoneal fluid be included in the AFS scoring
system because of its negative effect on the pregnancy out-
comes of infertile patients. In conclusion, when peritoneal
fluid is detected by transvaginal ultrasound in infertile women
with pelvic endometriosis, we suggest that patients receive
laparoscopic intervention or aspiration out of the peritoneal
fluid using ultrasound guidance prior to IUI treatment.
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